Keith A Marill, M.D.


Clinicn Investigator, Assc Prf
Emergency Medicine, Mass General Research Institute
Associate Professor of Emergency Medicine
Harvard Medical School
Associate Physician
Emergency Medicine, Massachusetts General Hospital
MD University of Rochester School of Medicine and Dentistry 1988
amiodarone; anti-arrhythmia agents; biometry; procainamide; subarachnoid hemorrhage; tachycardia; tachycardia, ventricular

Dr. Marill's research is focused on the diagnosis and treatment of dysrhythmic conditions and sudden cardiovascular death in the emergency setting. He has led groups that investigated the utility of medications such as lidocaine, amiodarone, procainamide, adenosine, and sotalol for the diagnosis and treatment of wide QRS complex and particularly ventricular tachycardia. This research has directly contributed to the ongoing evolution of the American Heart Association Advanced Cardiac Life Support (ACLS) algorithms.  It also has implications for the broader spectrum of ventricular dysrhythmias that are responsible for the majority of sudden cardiac death in the U.S.   Current research focuses on QT disease and its association with Torsades de Pointes and sudden death.   Dr. Marill has also investigated the utility of the serum d-dimer test for the diagnosis of acute aortic dissection.

Clinical research design and the advancement of the understanding and analysis of multivariate data and the evaluation of diagnostic tests is another area of interest.  Dr. Marill has lectured nationally and published both conceptual reviews and original research on these subjects

Publications Clinical Profile
kmarill@mgh.harvard.edu
6176438595

Emerson Place #0
0 Emerson Place
Boston, MA 02114